全文获取类型
收费全文 | 211530篇 |
免费 | 35414篇 |
国内免费 | 2519篇 |
专业分类
耳鼻咽喉 | 5933篇 |
儿科学 | 7042篇 |
妇产科学 | 3939篇 |
基础医学 | 13325篇 |
口腔科学 | 3129篇 |
临床医学 | 32349篇 |
内科学 | 59160篇 |
皮肤病学 | 8351篇 |
神经病学 | 20426篇 |
特种医学 | 8900篇 |
外国民族医学 | 45篇 |
外科学 | 48671篇 |
综合类 | 760篇 |
现状与发展 | 72篇 |
一般理论 | 83篇 |
预防医学 | 11827篇 |
眼科学 | 4490篇 |
药学 | 5430篇 |
中国医学 | 168篇 |
肿瘤学 | 15363篇 |
出版年
2024年 | 698篇 |
2023年 | 4933篇 |
2022年 | 1622篇 |
2021年 | 4027篇 |
2020年 | 6592篇 |
2019年 | 3025篇 |
2018年 | 8404篇 |
2017年 | 8014篇 |
2016年 | 9222篇 |
2015年 | 9374篇 |
2014年 | 16675篇 |
2013年 | 17759篇 |
2012年 | 8289篇 |
2011年 | 8380篇 |
2010年 | 12409篇 |
2009年 | 15909篇 |
2008年 | 8402篇 |
2007年 | 6784篇 |
2006年 | 9229篇 |
2005年 | 6394篇 |
2004年 | 5725篇 |
2003年 | 4463篇 |
2002年 | 4617篇 |
2001年 | 5907篇 |
2000年 | 5180篇 |
1999年 | 5148篇 |
1998年 | 4473篇 |
1997年 | 4157篇 |
1996年 | 3978篇 |
1995年 | 3841篇 |
1994年 | 2478篇 |
1993年 | 2145篇 |
1992年 | 2795篇 |
1991年 | 2766篇 |
1990年 | 2363篇 |
1989年 | 2460篇 |
1988年 | 2093篇 |
1987年 | 1943篇 |
1986年 | 1920篇 |
1985年 | 1663篇 |
1984年 | 1220篇 |
1983年 | 1154篇 |
1982年 | 961篇 |
1981年 | 828篇 |
1980年 | 731篇 |
1979年 | 928篇 |
1978年 | 701篇 |
1977年 | 757篇 |
1975年 | 650篇 |
1972年 | 642篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
Evolution of the sperm aster after microinjection of isolated human sperm centrosomes into meiotically mature human oocytes 总被引:3,自引:2,他引:1
This study examined the feasibility of isolating and transferringthe centrosome-containing region of spermatozoa to mature humanoocytes. The findings demonstrate that individual sperm centrosomescan be transferred and are capable of nucleating maternal tubulinto form a well-developed sperm aster in the recipient oocyte.The results are discussed with respect to centrosome functionin early human development and applications in clinical in-vitrofertilization in the treatment of certain forms of male factorinfertility. 相似文献
62.
63.
Peter Stone MD FRNZCOG FRCOG David Cook FRNZCOG MRCOG John Hutton PhD FRNZCOG FRCOG Gordon Purdie BSc Henry Murray MD FRNZCOG MRCOG Lauren Harcourt MPP BA 《The Australian & New Zealand journal of obstetrics & gynaecology》1995,35(1):32-37
Summary: This is the first report of the largest study of blood pressure measurement in pregnancy in a New Zealand population using standardized definitions and methodology. Over 3,800 women who delivered in an 8-month period in the Wellington region were included in the study. Blood pressure measurement and the presence of oedema and proteinuria were recorded from booking until delivery and in the puerperium. Only 2.7% of women were unable to be contacted after delivery for details on outcomes. The results established normal ranges for blood pressure throughout pregnancy. The data show that Mood pressure greater than 140/90 until 35 weeks' gestation is outside 2 standard deviations at all gestations and justifies using these measurements as the definition of hypertension in pregnancy. The fall in blood pressure in the 2nd trimester was less than 1 mm Ffg per week in both the systolic and diastolic pressures. This fall was smaller than previously recorded in other studies. Gestational hypertension was the commonest blood pressure abnormality occurring in 15.2% of the population. This represented 69% of the pregnant women with a hypertensive disorder. The overall incidence of both gestational hypertension and preeclampsia was 18.5% which is higher than reported in other parts of the world. In this study obesity was significantly associated with hypertensive disorders in pregnancy. An arm circumference of >33 cm, one of the measurements of obesity, was found in 6.8% of the study population. Even after the effect of arm circumference was taken into account, hypertensive disorders were also more common in Pacific Island women. Ankle oedema was significantly associated with the development of both gestational hypertension and preeclampsia but the incidence of oedema was noted in only 11.9% of the subjects. 相似文献
64.
Alexandros Karabetsos MD Dr ; George Karachalios MD Dr ; Paraskevoula Bourlinou RN Nurse ; Asimina Reppa RN Nurse ; Rozeta Koutri MD Dr ; Androniki Fotiadou MD Dr 《Headache》1997,37(1):12-14
The efficacy and safety of ketoprofen and paracetamol were compared for the treatment of acute migraine in a randomized, double-blind study of 64 patients. Thirty-four patients received ketoprofen 100 mg intramuscularly, and 30 patients received paracetamol 500 mg intramuscularly. Partial or complete relief of pain and other symptoms was achieved 15 to 20 minutes after administration in the ketoprofen group and within 35 minutes in the paracetamol group. Complete relief of pain was achieved within 30 to 40 minutes after ketoprofen in 28 patients (82.5%) compared to 5 patients (17.5%) in the paracetamol group. Six of the patients treated with ketoprofen needed a second dose for complete relief of pain during the 4-hour follow-up period. Side effects were rare and minimal. Our findings suggest that ketoprofen produced statistically significant benefit in the treatment of acute migraine. 相似文献
65.
T F Kruger J P Van der Merwe H J Odendaal F S Stander G M Grobler V A Hulme E L Erasmus K Coetzee M L Windt Y Swart 《Suid-Afrikaanse tydskrif vir geneeskunde》1990,77(12):634-636
The results of the in vitro fertilisation programme at Tygerberg Hospital for the period April 1983 to January 1988 are presented. Of the 1117 laparoscopies performed, 825 patients reached the transfer stage. A live-birth rate of 9.3% was achieved. The pregnancy rate after transfer of 4 embryos was 25.9% compared with 15.4% after 2 embryos and 10.8% after 3 embryos (P = less than 0.0001). The multiple pregnancy rate was 2.8% in the group receiving 2 embryos and 11.7% and 10.4% in those receiving 3 and 4 embryos, respectively. Of the 77 successful pregnancies (90 babies), 1 baby died at 34 weeks' gestation as the result of abruptio placentae due to preeclampsia and 1 cot death occurred. The only congenital abnormality encountered was a cleft palate. 相似文献
66.
J Komen P J Van den Dobbelsteen W J Slierendrecht W B Van Muiswinkel 《Transplantation》1990,49(4):788-793
The fate of skin allografts exchanged among heterozygous and homozygous gynogenetic common carp siblings, and among newly developed inbred strains and F1 hybrids, is described. Heterozygous gynogenetic offspring were produced by fertilizing eggs with UV-irradiated sperm and by treating the resulting zygote with a cold shock (0 degree C, 45 min). The temperature shock causes retention of the second polar body, which allows the eggs to develop into normal diploid fry. Homozygous gynogenetic offspring were similarly produced by using a heat shock (40 degrees C, 2 min), which suppresses the first mitotic division. Skin allografts exchanged among heterozygous gynogenetic carp exhibited prolonged survival, with some allografts (21.8%) surviving for over 28 days. Furthermore, a strong histocompatibility locus was seen to segregate in this group. In contrast, skin allografts exchanged among homozygous gynogenetic siblings were all rejected within 14 days (MST 9.4 days). New homozygous inbred strains, designated JJ and MM, were produced by gynogenetic reproduction of homozygous female carps, while F1 hybrids were produced by crossing of these homozygous females with homozygous male siblings. All grafts exchanged among members of the same strain were permanently accepted. Likewise grafts from homozygous strain members were accepted by fish from the related F1-hybrids, while the reverse grafts were rejected. These results provide evidence for the idea that in the carp histocompatibility genes exist at least one major locus and multiple minor loci, which are codominantly expressed. 相似文献
67.
Improved graft survival for flow cytometry and antihuman globulin crossmatch-negative retransplant recipients 总被引:1,自引:0,他引:1
R H Kerman C T Van Buren R M Lewis V DeVera V Baghdahsarian K Gerolami B D Kahan 《Transplantation》1990,49(1):52-56
We compared our standard NIH (extended incubation) crossmatch (XM) with antihuman globulin (AHG) and flow cytometry XMs and correlated the results with rejection episodes and graft survivals. For 89 CsA-Pred, primary renal allograft recipients, AHG and/or FCXM results did not improve on the NIH-XM-negative (NEG) graft survival results, whether testing pretransplant or historical (Hx) sera. Similarly, there was no association of a positive (POS) AHG or FCXM with increased rejection episodes in these primary recipients. However, for retransplant (Re-Tx) recipients a neg AHG or FCXM did discriminate fewer rejections and an improved graft survival compared with the NIH-XM-neg. results. The overall one-year graft survival for the 47 Re-Tx recipients studied herein was 66% (based on a neg pre-Tx NIH-XM). Pre-Tx AHG-NEG, Re-Tx recipients displayed an improved graft survival compared with NIH-XM NEG recipients (77% vs. 66%, P less than 0.05) and with AHG-POS recipients (77% vs. 47%, P less than 0.05). Similarly, pre-Tx, FCXM-NEG, Re-Tx recipients displayed improved graft survivals compared with NIH-XM-NEG recipients (83% vs. 66%, P less than 0.05) and FCXM-POS recipients (83% vs. 48%, P less than 0.05). Re-Tx recipients displaying a POS AHG and/or FCXM experienced a significantly greater number of rejections than NEG-XM recipients (P less than 0.05, respectively). The AHG and FCXM results correlated with rejections and graft survivals whether testing pre-Tx or Hx high-PRA sera. Re-Tx recipients who were AHG-XM-NEG but FCXM-POS, experienced more rejection episodes than recipients who displayed a negative XM reactivity for both AHG and FCXM (P less than 0.02), but with no resulting differences in graft survival. HLA matching, pre-Tx blood transfusions and PRA did not impact on these crossmatch and graft survival results. Use of AHG and/or FCXMs for Re-Tx, but not primary, recipients should help to improve graft survival for these high-risk recipients. 相似文献
68.
69.
70.